Animal Health
Biotech
GMP
Intellectual Property
Legal
Management Skills
Medical Devices
Pharmaceutical
Support Staff

Sponsoring & Exhibiting

For sponsorship and exhibition opportunities at Management Forum events click here

Event Management

To find out about event management click here

Speaking Opportunities

Speaking opportunities are available on selected Management Forum events, please contact us for further information

Management Forum Brochure

Download our catalogue here

Intellectual Property

The Impact of Patent Construction - How to Prove Infringement and Validity

15 May 2018

Standard
Excluding VAT @ 20.00%

Venue not yet confirmed

Enrol now

Bespoke training

We can customise this course to meet the requirements of your organisation.

Learn more

Course Overview

This seminar will:-

  • Examine the principles of claim construction in the three jurisdictions
  • Contrast the doctrines of equivalents and purposive construction
  • Analyse validity requirements
  • Illustrate the major issues with panel discussion, comparative examples and case studies

Why you should attend

This seminar provides:

  • A comprehensive overview of the principles of patent claim interpretation in the USA, UK and Germany
  • A comparison and explanation of the varying approaches for determining when a patent claim that does not literally describe an accused system is nonetheless infringed.
  • Exemplary fact scenarios, with comparisons of the USA, UK and Germany approaches to claim construction and validity determination
  • Recommendations for both litigating patents and preparing patent applications
  • Provision for participants to ask questions and discuss individual concerns through the day

Who should attend

  • Patent Professionals in private practice, including patent attorneys and lawyers
  • Heads of IP, Heads of Patents and in-house patent counsel at every level
  • Patent Engineers and inventors
  • All whose responsibilities include th need to understand the scope of patent coverage in USA, UK and Germany

Programme

1. Patent claims construction generally

A. In the USA

  • Inherent ambiguities of the ‘All Elements Rule’
  • Use of intrinsic and extrinsic evidence
  • Counterintuitive interpreations of ‘means for’ claims

B. In the UK

  • Interpreting the claim in the context of the specification and the art
  • The literal or primary meaning of the claim or integer
  • Purposive construction, as defined in Catnic and restated by the House of Lords in Amgen in 2004.
  • Any resideual relevance of the guidelines in Improver?
  • Compliance with EPC Article 69 and Protocol

C. In Germany

  • No claim construction below wording
  • ‘Purposive construction’ as part of literal wording
  • Meaning of ‘Means’ in claims and specification
  • Relationship between claims and specification

II Doctrines of equivalents and purposive construction

A. In the USA

  • Sub-tests for determining equivalents
  • Counterweights to ‘equivalence’
    • Vitiation
    • Prosecution history estoppel and its variants

B. In the UK

  • The effect of Amgen: How simple is the approach; are judges given any structured approach at all?
  • Continuing significance of ‘variants’ in slower-moving technologies?
  • Material considered by the court
  • Expert evidence
  • Compliance with EPC Article 69 and Protocol

C. In Germany

  • Expert evidence, admissible evidence
  • No Prosecution history estoppel
  • The ‘Formstein’ estoppel
  • Latest Supreme Court decisions on Equvalents (Permetrexed and Wärmetauscher)

VALIDITY ANALYSIS

A. In the USA

  • Four-part nonobvious analysis after KSR and the AIA
  • Reliance on the specification to construe the claims and avoid the art
  • Traps for European specifications filed in the USA

B. In the UK

  • Construction and the four-step ‘Pozzoli’ test for obviousness
  • Relevance of purposive construction to insufficiency analysis

C. In Germany

  • Split infringement/invalidity proceedings
  • Requirements for combination of documents

IV COMPARATIVE EXAMPLES AND CASE STUDIES

  • Presentation and panel discussion on the construction, infringement and validity of granted patents: comparative analysis and case studies

Continuing professional development

This course qualifies for the following CPD programmes:

  • CPD certificate of attendance: 5.50 hours
  • General Council of the Bar: 5.50 hours

Previous customers include...

  • AB Electrolux
  • Abzena plc
  • Alison Gallafent Limited
  • Appleyard Lees IP LLP
  • AstraZeneca
  • Boult Wade Tennant
  • British Telecommunications plc
  • Canon Europe Ltd
  • Coloplast A/S
  • Datalogic IP Tech Srl
  • De La Rue Holdings plc
  • DSM IP Assets BV
  • DuPont Nutrition Biosciences ApS
  • EGIS Pharmaceuticals PLC
  • Epping Hermann Fischer Patentanwalts GmbH
  • Hoffmann Eitle
  • Holme Patent A/S
  • Institut Straumann
  • J K Gadzama & Partners
  • Maiwald Patentanwalts GmbH
  • Metayage IP Strategy Consulting LLP
  • Müller Fottner Steinecke Rechtsanwalts- und Patentanwaltspartnerschaft mbB
  • Nestle Research Centre
  • Pfizer Limited
  • Ropes & Gray LLP
  • Solvay SA
  • Stratagem IPM Ltd
  • Swisscom (Switzerland) Ltd.
  • Syngenta
  • Volkswagen AG